TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 458.4M
Gross Profit 102.6M 22.39%
Operating Income 38.7M 8.44%
Net Income 20.7M 4.52%
EPS (Diluted) $0.24

Balance Sheet Metrics

Total Assets 2.0B
Total Liabilities 1.2B
Shareholders Equity 789.2M
Debt to Equity 1.53

Cash Flow Metrics

Operating Cash Flow -117.7M
Free Cash Flow -120.8M

Revenue & Profitability Trend

Pediatrix Medical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i2.0B2.0B2.0B1.9B1.7B
Cost of Goods Sold i1.6B1.6B1.5B1.4B1.3B
Gross Profit i454.3M421.6M467.0M513.2M449.3M
Gross Margin % i22.6%21.1%23.7%26.9%25.9%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i238.4M227.5M231.4M263.4M248.9M
Other Operating Expenses i-----
Total Operating Expenses i238.4M227.5M231.4M263.4M248.9M
Operating Income i183.7M157.9M200.0M217.7M171.9M
Operating Margin % i9.1%7.9%10.1%11.4%9.9%
Non-Operating Items
Interest Income i-----
Interest Expense i40.7M42.1M39.7M68.7M110.5M
Other Non-Operating Income-244.3M-164.1M-78.9M-13.8M-54.3M
Pre-tax Income i-101.3M-48.4M81.4M135.2M7.1M
Income Tax i-2.3M12.0M18.8M27.2M16.7M
Effective Tax Rate % i0.0%0.0%23.1%20.1%234.0%
Net Income i-99.1M-60.4M66.3M130.9M-796.5M
Net Margin % i-4.9%-3.0%3.4%6.9%-45.9%
Key Metrics
EBITDA i218.3M196.1M237.4M251.8M202.0M
EPS (Basic) i$-1.19$-0.72$0.80$1.52$-9.31
EPS (Diluted) i$-1.19$-0.73$0.79$1.52$-9.55
Basic Shares Outstanding i8333000084018023829470008642300085593000
Diluted Shares Outstanding i8333000084018023829470008642300085593000

Income Statement Trend

Pediatrix Medical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i229.9M73.3M9.8M387.4M1.1B
Short-term Investments i118.6M104.5M93.2M99.7M104.9M
Accounts Receivable i260.0M272.3M296.8M301.8M241.9M
Inventory i-----
Other Current Assets5.1M12.3M13.3M18.9M61.8M
Total Current Assets i639.6M483.5M428.0M840.6M1.5B
Non-Current Assets
Property, Plant & Equipment i194.6M278.3M302.1M290.0M259.0M
Goodwill i2.5B2.8B3.1B3.0B3.0B
Intangible Assets i11.6M21.2M18.5M21.6M26.6M
Long-term Investments-----
Other Non-Current Assets180.5M185.0M229.1M219.4M161.8M
Total Non-Current Assets i1.5B1.7B1.9B1.9B1.8B
Total Assets i2.2B2.2B2.3B2.7B3.3B
Liabilities
Current Liabilities
Accounts Payable i46.4M34.6M31.9M36.6M59.8M
Short-term Debt i33.2M36.0M36.5M22.2M21.2M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i434.1M388.9M427.0M427.4M444.3M
Non-Current Liabilities
Long-term Debt i629.1M665.7M680.6M1.0B1.8B
Deferred Tax Liabilities i34.2M34.3M33.6M41.4M61.7M
Other Non-Current Liabilities290.3M281.8M315.0M313.4M310.6M
Total Non-Current Liabilities i953.7M981.8M1.0B1.4B2.2B
Total Liabilities i1.4B1.4B1.5B1.8B2.6B
Equity
Common Stock i859.0K840.0K829.0K864.0K856.0K
Retained Earnings i-248.5M-149.5M-89.1M-155.4M-286.4M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i764.9M849.1M891.6M896.7M747.7M
Key Metrics
Total Debt i662.3M701.6M717.1M1.1B1.8B
Working Capital i205.5M94.5M1.0M413.2M1.1B

Balance Sheet Composition

Pediatrix Medical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-99.1M-60.4M62.6M108.0M-9.6M
Depreciation & Amortization i32.2M36.2M35.6M32.1M28.4M
Stock-Based Compensation i11.9M12.3M16.1M19.0M39.0M
Working Capital Changes i33.6M-221.0K15.5M-64.9M122.5M
Operating Cash Flow i-25.5M-10.8M108.9M65.0M223.6M
Investing Activities
Capital Expenditures i-22.0M-33.3M-29.7M-7.5M-28.8M
Acquisitions i-8.2M-6.7M-28.2M-29.9M-2.2M
Investment Purchases i-64.5M-31.9M-17.3M-35.1M-61.8M
Investment Sales i52.5M22.9M16.9M16.5M33.4M
Investing Cash Flow i-35.4M-48.2M-57.0M-55.4M-58.3M
Financing Activities
Share Repurchases i-1.7M-919.0K-88.5M-4.7M-8.5M
Dividends Paid i-----
Debt Issuance i235.5M470.0M1.5B00
Debt Repayment i-250.9M-489.1M-1.9B-762.7M-528.7M
Financing Cash Flow i-14.5M-25.7M-487.6M-760.1M-530.4M
Free Cash Flow i184.6M104.0M137.2M44.5M175.8M
Net Change in Cash i-75.4M-84.7M-435.6M-750.6M-365.1M

Cash Flow Trend

Pediatrix Medical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 12.63
Forward P/E 10.73
Price to Book 1.68
Price to Sales 0.74
PEG Ratio -0.10

Profitability Ratios

Profit Margin 5.66%
Operating Margin 13.59%
Return on Equity 14.27%
Return on Assets 6.50%

Financial Health

Current Ratio 1.80
Debt to Equity 77.91
Beta 1.21

Per Share Data

EPS (TTM) $1.30
Book Value per Share $9.79
Revenue per Share $23.07

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
md1.4B12.631.6814.27%5.66%77.91
HCA Healthcare 94.6B16.99-77.2513,631.68%8.21%-37.45
Tenet Healthcare 15.7B11.154.1829.65%7.18%158.70
Acadia Healthcare 2.1B14.760.664.83%4.31%74.74
Pacs 1.9B19.753.21110.96%2.59%469.36
Ardent Health 1.9B6.831.4824.32%4.11%138.17

Financial data is updated regularly. All figures are in the company's reporting currency.